Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Early Initiation of Calcineurin Inhibitor Induces CD8 + Transitory Exhausted-like and CD4 + Cytotoxic T Cells, Maintaining Responsiveness to PD-1 Blockade and Contributing to the Development of Chronic Gvhd after Post-Transplant Cyclophosphamide

Blood (2024) 144 (Supplement 1): 903.

https://doi.org/10.1182/blood-2024-197873

Published: 2024

Journal Articles

Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

Blood (2024) 144 (Supplement 1): 384.

https://doi.org/10.1182/blood-2024-203344

Published: 2024

Journal Articles

The Outcome of Fertility Preservation Strategy in Female Hematopoietic Stem Cell Transplant Recipients of Reproductive Age. Retrospective Study from the Kanto Study Group for Cell Therapy

Blood (2024) 144 (Supplement 1): 4925.

https://doi.org/10.1182/blood-2024-206182

Published: 2024

Journal Articles

Delayed Initiation of Calcineurin Inhibitor Is Critical for Tolerance Induction By Posttransplant Cyclophosphamide

Hajime Senjo, Daigo Hashimoto, Satomi Okada, Shimpei I Kubota, Ayumu Ito, Takashi Tanaka, Yumika Saito, Toru Miyajima, Wenyu Li, Zixuan Zhang, Shinpei Harada, Yuta Hasegawa, Hiroyuki Ohigashi, Takahide Ara, Yoshinori Hasegawa, Yoshihiro Inamoto, Masaaki Murakami, Takahiro Fukuda, Takanori Teshima

Blood (2023) 142 (Supplement 1): 2041.

https://doi.org/10.1182/blood-2023-181560

Published: 2023

Journal Articles

Novel biomarker-based probability engine

Yoshihiro Inamoto

Blood (2023) 141 (22): 2672–2673.

https://doi.org/10.1182/blood.2023020132

Published: 2023

Journal Articles

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Blood (2022) 140 (Supplement 1): 10598–10600.

https://doi.org/10.1182/blood-2022-158213

Published: 2022

Journal Articles

Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-137221

Published: 2020

Journal Articles

Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

Ayumi Fujimoto, MD, Nobuhiro Hiramoto, MD, Satoshi Yamasaki, MD PhD, Yoshihiro Inamoto, MD PhD, Naoyuki Uchida, MD PhD, Tetsuo Maeda, MD, Takehiko Mori, MD PhD, Yoshinobu Kanda, MD PhD, Tadakazu Kondo, MD PhD, Junji Tanaka, MD PhD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Masao Ogata, MD PhD, Ritsuro Suzuki, MD PhD

Blood (2018) 132 (Supplement 1): 250.

https://doi.org/10.1182/blood-2018-99-110424

Published: 2018

Journal Articles

Would Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation?

Hideki Nakasone, MD PhD, Koji Kawamura, MD PhD, Kimikazu Yakushijin, MD, Akihito Shinohara, MD PhD, Heiwa Kanamori, MD PhD, Kazuteru Ohashi, MD PhD, Takahiro Fukuda, MD PhD, Naoyuki Uchida, MD PhD, Hirohisa Nakamae, Junya Kanda, MD, Tatsuo Ichinohe, MD PhD, Yoshiko Atsuta, MD PhD, Yoshihiro Inamoto, MD PhD, Sachiko Seo, MD PhD, Fumihiko Kimura, Prof, MD PhD, Masao Ogata, MD PhD

Blood (2018) 132 (Supplement 1): 4669.

https://doi.org/10.1182/blood-2018-99-113790

Published: 2018

Journal Articles

Venous Thromboembolism in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Receiving Synthetic Retinoid Am80

Hisakazu Nishimori, MD PhD, Masashi Sawa, MD, Kazuteru Ohashi, MD PhD, Hirohisa Nakamae, MDPhD, Shin-ichiro Fujiwara, MD PhD, Yasuo Mori, MD PhD, Yoshihiro Inamoto, MD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 5482.

https://doi.org/10.1182/blood.V130.Suppl_1.5482.5482

Published: 2017

Journal Articles

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

Paul J. Martin, Barry E. Storer, Yoshihiro Inamoto, Mary E. D. Flowers, Paul A. Carpenter, Joseph Pidala, Jeanne Palmer, Mukta Arora, Madan Jagasia, Sally Arai, Corey S. Cutler, Stephanie J. Lee

Blood (2017) 130 (3): 360–367.

https://doi.org/10.1182/blood-2017-03-775767

Published: 2017

Includes: Supplemental data

Journal Articles

Intrabone Transplantation of a Single Cord Blood Unit Using Non-Irradiated Reduced-Intensity Conditioning

Blood (2016) 128 (22): 3390.

https://doi.org/10.1182/blood.V128.22.3390.3390

Published: 2016

Journal Articles

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

Blood (2016) 128 (19): 2350–2358.

https://doi.org/10.1182/blood-2015-09-669846

Published: 2016

Includes: Supplemental data

Journal Articles

Genetic risk factors for sclerotic graft-versus-host disease

Yoshihiro Inamoto, Paul J. Martin, Mary E. D. Flowers, Stephanie J. Lee, Paul A. Carpenter, Edus H. Warren, Daniel E. Geraghty, Ni Lee, Michael J. Boeckh, Barry E. Storer, David M. Levine, Wenhong Fan, Lue-Ping Zhao, John A. Hansen

Blood (2016) 128 (11): 1516–1524.

https://doi.org/10.1182/blood-2016-05-715342

Published: 2016

Includes: Supplemental data

Journal Articles

Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease

Jeanne Palmer, Xiaoyu Chai, Joseph Pidala, Yoshihiro Inamoto, Paul J. Martin, Barry Storer, Iskra Pusic, Mary E. D. Flowers, Mukta Arora, Steven Z. Pavletic, Stephanie J. Lee

Blood (2016) 127 (1): 160–166.

https://doi.org/10.1182/blood-2015-08-662874

Published: 2016

Includes: Supplemental data

Journal Articles

Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation

Yosuke Tanaka, MD, Saiko Kurosawa, MD, Kinuko Tajima, Yoshihiro Inamoto, MD PhD, Reiko Ito, MD, Takashi Tanaka, MD, Yoshitaka Inoue, MD, Takayuki Ozawa, MD, Akihisa Kawajiri, MD, Akio Onishi, MD, Keiji Okinaka, MD, Shigeo Fuji, MD, Sung-Won Kim, MD, Ryuji Tanosaki, MD PhD, Takuya Yamashita, MD PhD, Takahiro Fukuda, MD

Blood (2015) 126 (23): 3162.

https://doi.org/10.1182/blood.V126.23.3162.3162

Published: 2015

Journal Articles

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Alvaro Urbano-Ispizua, MD, Tao Wang, PhD, Michael T. Hemmer, MS, Corey S Cutler, MD MPH, Daniel R. Couriel, MD, Amin M. Alousi, MD, Mukta Arora, MD MS, Stephen R. Spellman, MBS

Blood (2014) 124 (21): 4383.

https://doi.org/10.1182/blood.V124.21.4383.4383

Published: 2014

Journal Articles

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Yoshihiro Inamoto, MD PhD, Paul J. Martin, MD, Mary E. Flowers, MD, Stephanie J. Lee, MD MPH, Paul A. Carpenter, MD, Edus Houston Warren, MD PhD, Michael Boeckh, MD, Barry E. Storer, PhD, David Levine, PhD, Wenhong Fan, Lue Ping Zhao, PhD, John A. Hansen, MD

Blood (2014) 124 (21): 665.

https://doi.org/10.1182/blood.V124.21.665.665

Published: 2014

Journal Articles

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Blood (2014) 124 (21): 209.

https://doi.org/10.1182/blood.V124.21.209.209

Published: 2014

Journal Articles

Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

Blood (2014) 124 (21): 1221.

https://doi.org/10.1182/blood.V124.21.1221.1221

Published: 2014

NARROW

Early Initiation of Calcineurin Inhibitor Induces CD8 + Transitory Exhausted-like and CD4 + Cytotoxic T Cells, Maintaining Responsiveness to PD-1 Blockade and Contributing to the Development of Chronic Gvhd after Post-Transplant Cyclophosphamide

Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGIC

The Outcome of Fertility Preservation Strategy in Female Hematopoietic Stem Cell Transplant Recipients of Reproductive Age. Retrospective Study from the Kanto Study Group for Cell Therapy

Delayed Initiation of Calcineurin Inhibitor Is Critical for Tolerance Induction By Posttransplant Cyclophosphamide

Novel biomarker-based probability engine

Donor Selection Considering Donor Age in Hematopoietic Cell Transplant Recipients 50-75 Years of Age

Comparison of Outcomes after Haploidentical Relative and HLA Matched Unrelated Donor Transplantation with Post-Transplant Cyclophosphamide Containing Gvhd Prophylaxis Regimens

Risk Factors and Predictive Scoring System for Post-Transplant Lymphoproliferative Disorder after Hematopoietic Stem Cell Transplantation

Would Bone Marrow be Associated with Superior Outcomes Compared with Peripheral Blood for Male Recipients with Female Donors in HLA-Matched Related Transplantation?

Venous Thromboembolism in Patients with Steroid-Refractory Chronic Graft-Versus-Host Disease Receiving Synthetic Retinoid Am80

An endpoint associated with clinical benefit after initial treatment of chronic graft-versus-host disease

Intrabone Transplantation of a Single Cord Blood Unit Using Non-Irradiated Reduced-Intensity Conditioning

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors

Genetic risk factors for sclerotic graft-versus-host disease

Predictors of survival, nonrelapse mortality, and failure-free survival in patients treated for chronic graft-versus-host disease

Secondary Cancer after Allogeneic Hematopoietic Stem Cell Transplantation

Comparison of Tacrolimus Versus Cyclosporine with Methotrexate for Immunosuppression after Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia: A CIBMTR Analysis

Genetic Risk Factors for Sclerotic Graft-Versus-Host Disease

Do Hematopoietic Cell Transplant Patients Treated on a Clinical Trial Do Better? Comparison of Characteristics and Outcomes of Patients Enrolled Versus Not Enrolled on Blood and Marrow Transplant Clinical Trials Network (BMT-CTN) 0201 Trial

Decision Analysis of Allogeneic Hematopoietic Stem Cell Transplantation Versus Chemotherapy in Cytogenetically Standard-Risk Acute Myeloid Leukemia in First Complete Remission: The Impact of FLT3-ITD Profile

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only